NCT00830570View on ClinicalTrials.gov

The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings

CompletedOBSERVATIONAL
Enrollment

1,635

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2010

Conditions
Embolism and ThrombosisEmbolismVascular DiseasesWarfarinVenous ThromboembolismThrombosisThromboembolism
Interventions
OTHER

CYP 2C9 and VKORC1 Testing for Warfarin

Test patients for their warfarin sensitivity and provide this information to their physician authorizing the test.

Trial Locations (1)

07003

Medco Health Solutions, Inc., Franklin Lakes

Sponsors

Collaborators (1)

Mayo Clinic
All Listed Sponsors
collaborator

Mayo Clinic

OTHER

collaborator

Washington University School of Medicine

OTHER

lead

Medco Health Solutions, Inc.

INDUSTRY